ARTICLE | Company News

Astellas extends OSI offer

April 1, 2010 12:48 AM UTC

Astellas Pharma Inc. (Tokyo:4503) extended its unsolicited tender offer of $52 per share for OSI Pharmaceuticals Inc. (NASDAQ:OSIP) to April 23 from March 31. As of Tuesday, 37,858 shares have been tendered, which represents less than 1% of OSI's 58.3 million shares outstanding at Feb. 15. On Monday, the companies signed a confidentiality agreement under which OSI will provide Astellas access to non-public information (See BioCentury Extra, Monday, March 29, 2010). ...